Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma.
Chanez P, Contin-Bordes C, Garcia G, Verkindre C, Didier A, De Blay F, de Lara MT, Blanco P, Moreau JF, Robinson P, Bourdeix I, Trunet P, Le Gros V, Humbert M, Molimard M.
Chanez P, et al. Among authors: molimard m.
Respir Med. 2010 Nov;104(11):1608-17. doi: 10.1016/j.rmed.2010.07.011. Epub 2010 Aug 30.
Respir Med. 2010.
PMID: 20801010
Free article.
Clinical Trial.